Damora Therapeutics (DMRA) Cash & Equivalents Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | 1,595.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,595.25% |
| Dec 31, 2025 | 1,717.45% |
| Sep 30, 2025 | -14.18% |
| Jun 30, 2025 | -55.46% |
| Mar 31, 2025 | -32.01% |
| Dec 31, 2024 | -43.96% |
| Sep 30, 2024 | -77.83% |
| Jun 30, 2024 | -0.24% |
| Mar 31, 2024 | -29.95% |
| Dec 31, 2023 | -22.85% |
| Sep 30, 2023 | 41.00% |
| Jun 30, 2023 | -22.95% |
| Mar 31, 2023 | -44.77% |
| Dec 31, 2022 | -47.60% |
| Sep 30, 2022 | -74.97% |
| Jun 30, 2022 | -56.59% |
| Mar 31, 2022 | -38.87% |
| Dec 31, 2021 | -61.76% |
| Sep 30, 2021 | 32.65% |
| Jun 30, 2021 | 91.50% |
| Mar 31, 2021 | 73.57% |
| Dec 31, 2020 | 1,348.56% |
| Sep 30, 2020 | 480.69% |